Cost-effectiveness of antibiotic-impregnated bone cement used in primary total hip arthroplasty

Journal of Bone and Joint Surgery

Volumn 91, Issue 3, 2009, Pages 634-641

  Cummins, Justin S ^a   Tomek, Ivan M ^a   Kantor, Stephen R ^a   Furnes, Ove ^a,b   Engesæter, Lars Birger ^a,b   Finlayson, Samuel R G ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 62549143996     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/JBJS.G.01029     Document Type: Article

References (24)

1. Lidgren L. Joint prosthetic infections: a success story. Acta Orthop Scand. 2001;72:553-6.
2. Walenkamp G. Surveillance of surgical-site infections in orthopedics. Acta Orthop Scand. 2003;74:172-4.
3. Bourne RB. Prophylactic use of antibiotic bone cement: an emerging standard-in the affirmative. J Arthroplasty. 2004;19(4 Suppl 1):69-72.
4. Espehaug B, Engesaeter LB, Vollset SE, Havelin LI, Langeland N. Antibiotic prophylaxis in total hip arthroplasty. Review of 10,905 primary cemented total hip replacements reported to the Norwegian Arthroplasty Register, 1987 to 1995. J Bone Joint Surg Br. 1997;79:590-5.
5. Engesaeter LB, Lie SA, Espehaug B, Furnes O, Vollset SE, Havelin LI. Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register. Acta Orthop Scand. 2003;74:644-51.
6. Malchau H, Herberts P, Ahnfelt L. Prognosis of total hip replacement in Sweden. Follow- up of 92,675 operations performed 1978-1990. Acta Orthop Scand. 1993;64:497-506.
7. Ahnfelt L, Herberts P, Malchau H, Andersson GB. Prognosis of total hip replacement. A Swedish multicenter study of 4,664 revisions. Acta Orthop Scand Suppl. 1990;238:1-26.
8. Bourne RB. Antibiotic bone cement approval: fuss-in at the Feds! Orthopedics. 2002;25:913-4.
9. Hanssen AD. Prophylactic use of antibiotic bone cement: an emerging standard-in opposition. J Arthroplasty. 2004;19(4 Suppl 1):73-7.
10. Joseph TN, Chen AL, Di Cesare PE. Use of antibiotic-impregnated cement in total joint arthroplasty. J Am Acad Orthop Surg. 2003;11:38-47.
11. Arciola CR, Campoccia D, Montanaro L. Effects on antibiotic resistance of Staphylococcus epidermidis following adhesion to polymethylmethacrylate and to silicone surfaces. Biomaterials. 2002;23:1495-502.
12. Tunney MM, Ramage G, Patrick S, Nixon JR, Murphy PG, Gorman SP. Antimicrobial susceptibility of bacteria isolated from orthopedic implants following revision hip surgery. Antimicrob Agents Chemother. 1998;42:3002-5.
13. Hunink MGM, Glasziou P, Siegel JE, Weeks J, Pliskin J, Elstein AS, Weinstein M. Decision making in health and medicine: integrating evidence and values. Cambridge: Cambridge University Press; 2004.
14. Gold MR, Siegel JE, Russell LB, Weinstein MC, editors. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
15. Persson U, Persson M, Malchau H. The economics of preventing revisions in total hip replacement. Acta Orthop Scand. 1999;70:163-9.
16. Laupacis A, Bourne R, Rorabeck C, Feeny D, Wong C, Tugwell P, Leslie K, Bullas R. The effect of elective total hip replacement on health-related quality of life. J Bone Joint Surg Am. 1993;75:1619-26.
17. Rorabeck CH, Bourne RB, Mulliken BD, Nayak N, Laupacis A, Tugwell P, Feeney D. Comparative results of cemented and cementless total hip arthroplasty. Clin Orthop Relat Res. 1996;325:330-44.
18. Hozack WJ, Rothman RH, Albert TJ, Balderston RA, Eng K. Relationship of total hip arthroplasty outcomes to other orthopaedic procedures. Clin Orthop Relat Res. 1997;344:88-93.
19. Antoniou J, Martineau PA, Filion KB, Haider S, Zukor DJ, Huk OL, Pilote L, Eisenberg MJ. In-hospital cost of total hip arthroplasty in Canada and the United States. J Bone Joint Surg Am. 2004;86:2435-9.
20. Barrack RL. The evolving cost spectrum of revision hip arthroplasty. Orthopedics. 1999;22:865-6.
21. Bozic KJ, Ries MD. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am. 2005;87:1746-51.
22. Bozic KJ, Katz P, Cisternas M, Ono L, Ries MD, Showstack J. Hospital resource utilization for primary and revision total hip arthroplasty. J Bone Joint Surg Am. 2005;87:570-6.
23. McQueen M, Littlejohn A, Hughes SP. A comparison of systemic cefuroxime and cefuroxime loaded bone cement in the prevention of early infection after total joint replacement. Int Orthop. 1987;11:241-3.
24. McQueen MM, Hughes SP, May P, Verity L. Cefuroxime in total joint arthroplasty. Intravenous or in bone cement. J Arthroplasty. 1990;5:169-72.